Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized, Controlled Clinical Trial.
Ava Y XuGustavo E VelásquezNan ZhangVincent K ChangPatrick Peter John PhillipsPayam NahidSusan E DormanEkaterina V KurbatovaWilliam C WhitworthErin SizemoreKia BryantWendy CarrNicole E BrownMelissa L EngleNguyen Viet NhungPheona NsubugaAndreas H DiaconKelly E DooleyRichard E ChaissonSusan SwindellsRadojka M Savicnull nullPublished in: American journal of respiratory and critical care medicine (2024)
gov, ID: NCT02410772.